BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23285778)

  • 21. Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes.
    Podevin P; Carpentier A; Pène V; Aoudjehane L; Carrière M; Zaïdi S; Hernandez C; Calle V; Méritet JF; Scatton O; Dreux M; Cosset FL; Wakita T; Bartenschlager R; Demignot S; Conti F; Rosenberg AR; Calmus Y
    Gastroenterology; 2010 Oct; 139(4):1355-64. PubMed ID: 20600021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro replication models for the hepatitis C virus.
    Sheehy P; Mullan B; Moreau I; Kenny-Walsh E; Shanahan F; Scallan M; Fanning LJ
    J Viral Hepat; 2007 Jan; 14(1):2-10. PubMed ID: 17212638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus.
    Roelandt P; Obeid S; Paeshuyse J; Vanhove J; Van Lommel A; Nahmias Y; Nevens F; Neyts J; Verfaillie CM
    J Hepatol; 2012 Aug; 57(2):246-51. PubMed ID: 22521345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic analysis of HuH-7 cells harboring in vitro-transcribed full-length hepatitis C virus 1b RNA.
    Xun M; Zhao SH; Cao CX; Song J; Shao MM; Chu YL
    Acta Pharmacol Sin; 2008 Jun; 29(6):720-7. PubMed ID: 18501119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interference of replication between hepatitis B and C viruses in patients infected with HIV.
    Yang RR; Gui X; Chen XY; Zhu Y
    J Med Virol; 2011 Jul; 83(7):1159-64. PubMed ID: 21567419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A compartmentalization model of hepatitis C virus replication: an appropriate distribution of HCV RNA for the effective replication.
    Nakabayashi J
    J Theor Biol; 2012 May; 300():110-7. PubMed ID: 22286015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human immunodeficiency virus enhances hepatitis C virus replication by differential regulation of IFN and TGF family genes.
    Zhang X; Daucher M; Baeza J; Kim CW; Russell R; Kottilil S
    J Med Virol; 2012 Sep; 84(9):1344-52. PubMed ID: 22825812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview: in vitro models of HCV replication in different cell cultures.
    Tariq H; Manzoor S; Parvaiz F; Javed F; Fatima K; Qadri I
    Infect Genet Evol; 2012 Jan; 12(1):13-20. PubMed ID: 22061839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype 1a HCV (H77S) infection system.
    Yi M; Lemon SM
    Methods Mol Biol; 2009; 510():337-46. PubMed ID: 19009273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus enters human peripheral neuroblastoma cells - evidence for extra-hepatic cells sustaining hepatitis C virus penetration.
    Bürgel B; Friesland M; Koch A; Manns MP; Wedemeyer H; Weissenborn K; Schulz-Schaeffer WJ; Pietschmann T; Steinmann E; Ciesek S
    J Viral Hepat; 2011 Aug; 18(8):562-70. PubMed ID: 20579278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of JFH-1 strain and development of an HCV infection system.
    Wakita T
    Methods Mol Biol; 2009; 510():305-27. PubMed ID: 19009271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA.
    Abe K; Ikeda M; Dansako H; Naka K; Kato N
    Virus Res; 2007 Apr; 125(1):88-97. PubMed ID: 17239465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro infection of human liver cancer cell line HepG2 with HCV].
    Song ZQ; Hao F; Ma QY; Wang YM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):77-80. PubMed ID: 12870026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro.
    Paeshuyse J; Kaul A; De Clercq E; Rosenwirth B; Dumont JM; Scalfaro P; Bartenschlager R; Neyts J
    Hepatology; 2006 Apr; 43(4):761-70. PubMed ID: 16557546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Full-length infectious HCV chimeras.
    Pietschmann T
    Methods Mol Biol; 2009; 510():347-59. PubMed ID: 19009274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production and characterization of HCV particles from serum-free culture.
    Akazawa D; Morikawa K; Omi N; Takahashi H; Nakamura N; Mochizuki H; Date T; Ishii K; Suzuki T; Wakita T
    Vaccine; 2011 Jun; 29(29-30):4821-8. PubMed ID: 21550372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel helper-dependent adenovirus-based cell culture model for Hepatitis C virus replication and production.
    Zhou X; Zeng Y; Li J; Guo Y; Fu Y; He J; Sun S; Zhou Y
    Virol J; 2013 Aug; 10():273. PubMed ID: 23987099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation and quantitation of infectious hepatitis C virus derived from cell culture (HCVcc).
    Paulson MS
    Curr Protoc Pharmacol; 2010 Dec; Chapter 13():Unit 13B.4. PubMed ID: 21935897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A subclone of HuH-7 with enhanced intracellular hepatitis C virus production and evasion of virus related-cell cycle arrest.
    Murayama A; Sugiyama N; Yoshimura S; Ishihara-Sugano M; Masaki T; Kim S; Wakita T; Mishiro S; Kato T
    PLoS One; 2012; 7(12):e52697. PubMed ID: 23285155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum-derived hepatitis C virus 1a infection of human astrocyte cell line SVG.
    Rajalakshmy AR; Malathi J; Madhavan HN
    J Viral Hepat; 2016 Mar; 23(3):211-6. PubMed ID: 26469941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.